BIRC3 and B-cell chronic lymphocytic leukemia: BIRC3 deletions coexist with ATM deletions, both have prognostic value in CLL [27,28,29], being patients with a biallelic alteration (deletion and mutation) those with a significantly shorter time to first treatment (TTFT) [30].